Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer
Ecke, Thorsten, Huang-Tiel, Hui-Juan, Golka, Klaus, Selinski, Silvia, Geis, Berit, Koswig, Stephan, Bathe, Katrin, Hallmann, Steffen, Gerullis, HolgerVolume:
17
Language:
english
Journal:
International Journal of Molecular Sciences
DOI:
10.3390/ijms17111879
Date:
November, 2016
File:
PDF, 815 KB
english, 2016